Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd Therapy Administered Into Lymph Nodes Combined With Oral Vitamin D to Investigate the Impact on the Progression of Type 1 Diabetes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03345004
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:51.401429+00:00
Published At
2023-01-09T00:00:00+00:00
Record Updated At
2023-01-09
Results Posted At
2023-01-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Diabetes Mellitus, Type 1", "Diabetes Mellitus", "Autoimmune Diseases", "Metabolic Disease", "Glucose Metabolism Disorders", "Immune System Diseases", "Endocrine System Diseases", "Juvenile Diabetes", "Insulin Dependent Diabetes", "Autoimmune Diabetes", "Vitamin D", "Physiological Effects of Drugs"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-01-09"
protocolSection.identificationModule.nctId
"NCT03345004"
protocolSection.identificationModule.officialTitle
"A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd Therapy Administered Into Lymph Nodes Combined With Oral Vitamin D to Investigate the Impact on the Progression of Type 1 Diabetes"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-01-09"

Study condition terms

  • Diabetes Mellitus, Type 1 (protocolSection.conditionsModule.conditions)
  • Diabetes Mellitus (protocolSection.conditionsModule.conditions)
  • Autoimmune Diseases (protocolSection.conditionsModule.conditions)
  • Metabolic Disease (protocolSection.conditionsModule.conditions)
  • Glucose Metabolism Disorders (protocolSection.conditionsModule.conditions)
  • Immune System Diseases (protocolSection.conditionsModule.conditions)
  • Endocrine System Diseases (protocolSection.conditionsModule.conditions)
  • Juvenile Diabetes (protocolSection.conditionsModule.conditions)
  • Insulin Dependent Diabetes (protocolSection.conditionsModule.conditions)
  • Autoimmune Diabetes (protocolSection.conditionsModule.conditions)
  • Vitamin D (protocolSection.conditionsModule.conditions)
  • Physiological Effects of Drugs (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.